| Literature DB >> 36217392 |
Miriam de Toni Abboud1,2, Gabriel Veber Moisés da Silva2, Antonio Rebello Horta Gorgen2, Patric Machado Tavares2, Francisco E Martins3, Tiago Elias Rosito1,2.
Abstract
Background: Gender-affirming surgery is classically done using the penile inversion vaginoplasty technique, however in some patients it may not promote adequate depth. In patients whose vaginal conduits became short or stenotic, we propose to perform a secondary vaginoplasty using an abdominal free skin mesh graft. In this study, we present ours results of a series of cases using this technique.Entities:
Keywords: Gender affirmation surgery; gender dysphoria; skin graft; vaginoplasty
Year: 2022 PMID: 36217392 PMCID: PMC9547157 DOI: 10.21037/tau-22-215
Source DB: PubMed Journal: Transl Androl Urol ISSN: 2223-4683
Figure 1Graft harvesting and preparation. (A) Drawings of the skin incision. (B) Full skin graft harvesting from the lower abdomen. (C) Preparation of the graft; removal of adipose tissue. (D) Aspect of the graft after the incisions (mesh skin principle).
Figure 2Mold preparation and graft placement. (A) Suture of the graft over a 12 cm rigid silicone mold. (B) Final aspect of the graft on the silicone mold. (C) Placement of the silicone mold with the graft in the neovagina conduit.
Patient’s characteristics, and comorbidities and hormonal status; surgery success’ rate and complications’ rate
| Characteristics | n=35 (%) |
|---|---|
| Age (years), median [interquartile range] | 41 [37–50.5] |
| Caucasian | 29 (82.9%) |
| HIV | 6 (17.1%) |
| Hypertension | 2 (5.7%) |
| Diabetes mellitus | 2 (5.7%) |
| Smoking | 4 (11.4%) |
| Syphilis | 2 (5.7%) |
| Hormonal replacement therapy | 25 (71.4%) |
| Time to vaginoplasty (months), median [interquartile range] | 6.0 [4.0–24.0] |
| Success rates | |
| Functional neovagina | 27 (77.1%) |
| Personal satisfaction | 27 (77.1%) |
| Complications | |
| Any postoperative complications | 10 (28.6%) |
| Suture dehiscence | 1 (2.9%) |
| Urethral stenosis | 0 (0.0%) |
| Urethral fistula | 1 (2.9%) |
| Rectal fistula | 3 (8.6%) |
| Neovagina stenosis | 8 (22.9%) |
HIV, human immunodeficiency virus.
Correlation between patients’ characteristics, surgical time, success rates and complications
| Variable | Complications, P (rs) | ||||
|---|---|---|---|---|---|
| Complications | Urethral fistula | Rectal fistula | Neovagina stenosis | Dehiscence | |
| Ethnics | P>0.10 | P>0.10 | P>0.10 | P>0.10 | P>0.10 |
| HIV | P=0.092, rs=0.324 | P>0.10 | P>0.10 | P=0.020*, rs=0.438 | P>0.10 |
| Hypertension | P>0.10 | P>0.10 | P>0.10 | P>0.10 | P>0.10 |
| Diabetes | P>0.10 | P>0.10 | P>0.10 | P>0.10 | P>0.10 |
| Tabagism | P>0.10 | P>0.10 | P=0.002*, rs=0.556 | P=0.369, rs=0.054 | P>0.10 |
| Depression | P>0.10 | P=0.002*, rs=0.556 | P>0.10 | P=0.039*, rs=0.386 | P=0.002*, rs=0.556 |
| Syphilis | P>0.10 | P>0.10 | P>0.10 | P>0.10 | P>0.10 |
| Hormonal therapy | P>0.10 | – | P>0.10 | P>0.10 | – |
| Age | P>0.10 | P>0.10 | P>0.10 | P>0.10 | P>0.10 |
| Surgical time | P>0.10 | P>0.10 | P>0.10 | P>0.10 | P>0.10 |
| Time to vaginoplasty | P=0.056, rs=0.341 | P>0.10 | P>0.10 | P>0.10 | P>0.10 |
*, correlation with statistical significance. HIV, human immunodeficiency virus; rs, Spearman rank correlation.